OST31-164

Emerald Clinical Inc. · Phase 2 active Small molecule

At a glance

Generic name	OST31-164
Sponsor	Emerald Clinical Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Osteosarcoma Maintenance Therapy With OST31-164 (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

OST31-164 CI brief — competitive landscape report
OST31-164 updates RSS · CI watch RSS
Emerald Clinical Inc. portfolio CI